Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Acta Oncologica (Stockholm, Sweden)|June 15, 2007
Barriers to palliative radiotherapy referral: a Canadian perspectiveRajiv S Samant, Edward Fitzgibbon, Joanne Meng, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2005
Family physicians' perspectives regarding palliative radiotherapyRajiv S Samant, Edward Fitzgibbon, Joanne Meng, et al.Radiation Oncology (London, England)|July 24, 2014
IMRT sparing of normal tissues in locoregional treatment of breast cancerJean-Michel Caudrelier, Joanne Meng, Bernd Esche, et al.Current Oncology (Toronto, Ont.)|November 24, 2023
Cancer Center Staff Satisfaction: Descriptive Results of a Canadian StudyRajiv Samant, Ege Babadagli, Selena Laprade, et al.Journal of the National Cancer Institute|May 22, 2016
Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617Bree R Eaton, Stephanie L Pugh, Jeffrey D Bradley, et al.The Lancet. Oncology|January 21, 2015
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyJeffrey D Bradley, Rebecca Paulus, Ritsuko Komaki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung CancerJeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.Pageof 1